Israel’s Evogene reports positive field trial results in Ag-biologicals program

2016-11-17 09:46:11

Evogene’s candidate microbial strains demonstrate positive efficacy and stability results in first year of field testing in corn under drought conditionsBy Team ABLEEvogene, Israel’s leading company that works on solutions for improvement of crop productivity and economics for the food, feed and fuel industries, has announced positive field trial results conducted in Israel from its Ag-biologi

Read more

DBT, ICAR organize International Research Conference on Brucellosis in New Delhi

2016-11-17 09:43:38

The conference aims to serve as the premier international forum for researchers, veterinarians, medical doctors, and public health professionals interested in all aspects of brucellosis.By Team ABLEThe Department of Biotechnology in collaboration with Indian Council of Agricultural Research is organizing the “Brucellosis 2016 International Research Conference”, including the 69th Annual Brucel

Read more

Novozymes expands production capabilities in India

2016-11-16 10:15:06

To cater to the growing India and South-East Asia markets, Novozymes will invest Rs 300 crore in the first phase to build a new production and supply chain facility at Patalganga near MumbaiBy Team ABLENovozymes, world’s largest supplier of industrial enzymes, with a market share of 48% globally, has obtained land in the Patalganga industrial area near Mumbai, on India’s west coast to expand i

Read more

Global biosimilars market to reach $6.22 billion by 2020

2016-11-16 10:09:31

The global biosimilars market is expected to reach $6.22 billion by 2020 from $2.29 billion in 2015, at a CAGR of 22.1% from 2015 to 2020, says MarketsandMarkets study.By Team ABLEA recent report released by MarketsandMarkets on Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucago

Read more

Pfizer, National Cancer Institute collaborate to study three cancer immunotherapeutics

2016-11-16 10:07:07

Pfizer has entered into a Cooperative Research and Development Agreement with the National Cancer Institute to arrange and conduct preclinical and clinical trials to evaluate three investigational cancer immunotherapy agentsBy Team ABLEGlobal pharmaceutical company Pfizer has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI), part of the

Read more

Global health organizations note that hundreds of children still die of Measles every day

2016-11-15 10:40:41

Despite a 79% worldwide decrease in measles deaths between 2000 and 2015, nearly 400 children still die from the disease every day, leading health organizations said in a report released on Nov 10, 2016By Team ABLEDespite a 79% worldwide decrease in measles deaths between 2000 and 2015, nearly 400 children still die from the disease every day, leading health organizations said in a report released

Read more

New technologies could revolutionize drug discovery: SECFilings.com

2016-11-15 10:38:41

The cost to develop a new pharmaceutical drug has more than doubled over the past ten years to $2.6 billion. These high costs make a drug failure extremely detrimental to a company\'s financial outlook. Endonovo\'s Cytotronics is being developed as a high-fidelity drug development and toxicology testing platform designed to catch problems early on.By Team ABLEUS-headquartered SECFilings.com, a lea

Read more

FDA rejects Dynavax’ HEPLISAV-B vaccine; calls for resubmission of Biologics License Application

2016-11-15 10:37:19

The US FDA rejected Dynavax’ hepatitis B vaccine for the second time in three years, casting doubts on the drug developer\'s ability to bring its main drug to the market on its own.By Team ABLECalifornia-located Dynavax Technologies Corporation has received a Complete Response Letter (CRL) from the U S Food and Drug Administration (FDA) regarding its Biologics License Application (BLA) for HEPLI

Read more

Dr Harsh Vardhan inaugurates CSIR’s Platinum Jubilee Techno-Fest 2016

2016-11-15 10:35:20

Dr Harsh Vardhan, highlighted CSIR’s efforts to showcase its knowledgebase that it has delivered to the nation during its journey of 75 years through its mega expo, CSIR Platinum Jubilee Technofest 2016By Team ABLEOn Sunday, November 13, 2016, The Council for Scientific and Industrial Research (CSIR) celebrated its Platinum Jubilee for this year. The Union Minister of Science & Technology an

Read more

India on a mission to end TB: ICMR acts under PM Narendra Modi’s vision to curb TB

2016-11-14 06:57:18

In a new initiative, ICMR’s India TB Research and Development Corporation will bring together all major national and international stakeholders to develop new tools for TB diagnosis and intervention. By Team ABLEIn a pledge to make India Tuberculosis (TB) free, ICMR has stepped up efforts to takes a lead in TB research in a unique mission mode to end the disease that looms the country at large.

Read more